Related references
Note: Only part of the references are listed.Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Natalie K. Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2023)
Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy
Dario Gosmann et al.
EJNMMI RESEARCH (2022)
Immune Epigenetic Crosstalk Between Malignant B Cells and the Tumor Microenvironment in B Cell Lymphoma
Patrizia Mondello et al.
FRONTIERS IN GENETICS (2022)
Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas
Nuria Profitos-Peleja et al.
CANCERS (2022)
The genomic and transcriptional landscape of primary central nervous system lymphoma
Josefine Radke et al.
NATURE COMMUNICATIONS (2022)
Phenotype, Function, and Clinical Significance of CD26+ and CD161+ Tregs in Splenic Marginal Zone Lymphoma
Xinyi Tang et al.
CLINICAL CANCER RESEARCH (2022)
CC chemokine receptor 2 (CCR2) expression promotes diffuse large B-Cell lymphoma survival and invasion
Quan-Quan Hu et al.
LABORATORY INVESTIGATION (2022)
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression
Guangchun Han et al.
BLOOD CANCER DISCOVERY (2022)
Natural killer cells in antitumour adoptive cell immunotherapy
Tamara J. Laskowski et al.
NATURE REVIEWS CANCER (2022)
Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma
Jiaojiao Guo et al.
CANCER GENE THERAPY (2021)
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Chloe Steen et al.
CANCER CELL (2021)
PHOENIX rises: Genomic-based therapies for diffuse large B cell lymphoma
Patrizia Mondello et al.
CANCER CELL (2021)
The SIRPα-CD47 immune checkpoint in NK cells
Tobias Deuse et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Tumor-Infiltrating Natural Killer Cells
Beatriz Cozar et al.
CANCER DISCOVERY (2021)
Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures
Nikita Kotlov et al.
CANCER DISCOVERY (2021)
Reduced CD5 on CD8+ T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function
Faizah Alotaibi et al.
FRONTIERS IN IMMUNOLOGY (2021)
PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients
Chiara Tarantelli et al.
CANCERS (2021)
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma
Juan Garcia Valero et al.
LEUKEMIA (2021)
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano et al.
CANCER DISCOVERY (2021)
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
Navid Sobhani et al.
CANCERS (2021)
Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity
Jenna L. Collier et al.
NATURE IMMUNOLOGY (2021)
Expression of Foxp3 by T follicular helper cells in end-stage germinal centers
Johanne T. Jacobsen et al.
SCIENCE (2021)
Lack of intrafollicular memory CD4+T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
Patrizia Mondello et al.
BLOOD CANCER JOURNAL (2021)
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
Yao-Hui Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson et al.
NATURE REVIEWS CANCER (2021)
In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes
Maryam Moradi-Chaleshtori et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
TIGIT as an emerging immune checkpoint
H. Harjunpaa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti-PD-1 in a Murine Model of Cutaneous T -Cell Lymphoma (CTCL)
Xuesong Wu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis
Rebecca L. King et al.
VIRCHOWS ARCHIV (2020)
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma
Patrizia Mondello et al.
CANCER DISCOVERY (2020)
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy
Lukas Marcelis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
T follicular helper cells in germinal center B cell selection and lymphomagenesis
Michelle A. Mintz et al.
IMMUNOLOGICAL REVIEWS (2020)
TIGIT Expression Is Associated with T-cell Suppression and Exhaustion and Predicts Clinical Outcome and Anti-PD-1 Response in Follicular Lymphoma
Zhi-Zhang Yang et al.
CLINICAL CANCER RESEARCH (2020)
T follicular helper cell-mediated IL-21 production suppresses FOXP3 expression of T follicular regulatory-like cells in diffuse large B cell lymphoma patients
Xiaomei Ma et al.
HUMAN IMMUNOLOGY (2020)
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment
Kaiyue Wu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Role of CD47 in Hematological Malignancies
Entsar Eladl et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
Barzin Y. Nabet et al.
CELL (2020)
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
Eduardo Bonavita et al.
IMMUNITY (2020)
Potential Roles of Tumor Cell- and Stroma Cell-Derived Small Extracellular Vesicles in Promoting a Pro-Angiogenic Tumor Microenvironment
Nils Ludwig et al.
CANCERS (2020)
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Daisuke Ennishi et al.
CANCER DISCOVERY (2019)
Targeting Tumor-Associated Macrophages in Cancer
Paulina Pathria et al.
TRENDS IN IMMUNOLOGY (2019)
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
Joseph Cursons et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer
WeiHong Ren et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma
Joseph M. Tuscano et al.
CLINICAL CANCER RESEARCH (2019)
Primary central nervous system lymphoma: Novel precision therapies
Patrizia Mondello et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
Xinyu Tian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
Amy J. Petty et al.
CELLS (2019)
Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly
Wagner A. Poles et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Hanna Grauers Wiktorin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530
Silvia L. Locatelli et al.
CLINICAL CANCER RESEARCH (2019)
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
Jacoline E. C. Bromberg et al.
LANCET ONCOLOGY (2019)
Turning foes to friends: targeting cancer-associated fibroblasts
Xueman Chen et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Defining 'T cell exhaustion'
Christian U. Blank et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma
Anna Stelling et al.
BLOOD (2018)
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
Frank Vari et al.
BLOOD (2018)
The prevalence and function of CD4+ CXCR5+ Foxp3+ follicular regulatory T cells in diffuse large B cell lymphoma
Zhanshan Cha et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Assaf Marcus et al.
IMMUNITY (2018)
PD-L1 Mediates Dysfunction in Activated PD-1(+) NK Cells in Head and Neck Cancer Patients
Fernando Concha-Benavente et al.
CANCER IMMUNOLOGY RESEARCH (2018)
PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity
Larissa S. Carnevalli et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young et al.
CANCER RESEARCH (2018)
A Paradoxical Correlation of Cancer-Associated Fibroblasts With Survival Outcomes in B-Cell Lymphomas and Carcinomas
Marcela Haro et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
Dhifaf Sarha et al.
BLOOD ADVANCES (2018)
Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era
Robert Kridel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Lenalidomide potentiates CD4+CD25+Treg-related suppression of lymphoma B-cell proliferation
Monika Anna Grygorowicz et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
Ruea-Yea Huang et al.
ONCOIMMUNOLOGY (2017)
MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma
Zhen Xu et al.
FEBS JOURNAL (2017)
The role of follicular T helper cells in patients with malignant lymphoid disease
Dong-Ming Zhou et al.
HEMATOLOGY (2017)
The future of immune checkpoint cancer therapy after PD-1 and CTLA-4
Andrew W. Hahn et al.
IMMUNOTHERAPY (2017)
Effector CD8 T cells dedifferentiate into long-lived memory cells
Ben Youngblood et al.
NATURE (2017)
Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
Y. Liu et al.
ONCOGENE (2017)
Transcriptional Regulation of Tissue-Resident Lymphocytes
Laura K. Mackay et al.
TRENDS IN IMMUNOLOGY (2017)
Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
Shomyseh Sanjabi et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Sara Trabanelli et al.
NATURE COMMUNICATIONS (2017)
Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma
Zhi-Zhang Yang et al.
ONCOTARGET (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao et al.
NATURE IMMUNOLOGY (2017)
B cell regulation in cancer and anti-Xtumor immunity
Anushruti Sarvaria et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Michail S. Lionakis et al.
CANCER CELL (2017)
IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma
Shubham Pandey et al.
BLOOD (2017)
Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified
Shoko Nakayama et al.
BLOOD ADVANCES (2017)
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations
Patrizia Mondello et al.
JCI INSIGHT (2017)
Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment
Frederick S. Varn et al.
CANCER RESEARCH (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
Imane Azzaoui et al.
BLOOD (2016)
Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells
Nicholas D. Huntington et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Leonid Cherkassky et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Emerging concepts and future challenges in innate lymphoid cell biology
Elia D. Tait Wojno et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity
Yoichiro Ohne et al.
NATURE IMMUNOLOGY (2016)
IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs
Suzanne M. Bal et al.
NATURE IMMUNOLOGY (2016)
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Christoph S. N. Klose et al.
NATURE IMMUNOLOGY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Asma Beldi-Ferchiou et al.
ONCOTARGET (2016)
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients
Olivia Marini et al.
ONCOTARGET (2016)
ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation
Claire Pearson et al.
ELIFE (2016)
Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation
Pushpa Pandiyan et al.
FRONTIERS IN IMMUNOLOGY (2016)
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia
Emily M. McWilliams et al.
ONCOIMMUNOLOGY (2016)
M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma
Long Shen et al.
SCIENTIFIC REPORTS (2016)
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
Iryna Saranchova et al.
SCIENTIFIC REPORTS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
Rachel A. Burga et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair
Dietmar M. W. Zaiss et al.
IMMUNITY (2015)
Interleukin-12 and-23 Control Plasticity of CD127+ Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria
Jochem H. Bernink et al.
IMMUNITY (2015)
Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis
Thibault Griseri et al.
IMMUNITY (2015)
Innate lymphoid cells: A new paradigm in immunology
Gerard Eberl et al.
SCIENCE (2015)
Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas
Murielle Gregoire et al.
ONCOTARGET (2015)
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Ruea-Yea Huang et al.
ONCOTARGET (2015)
Apoptosis of tumor infiltrating effector TIM-3+CD8+T cells in colon cancer
Chiao-Wen Kang et al.
SCIENTIFIC REPORTS (2015)
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy
Alessandra Romano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Germinal centres and B cell lymphomagenesis
Katia Basso et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
Ruth Scherz-Shouval et al.
CELL (2014)
Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages
Christoph S. N. Klose et al.
CELL (2014)
Innate Lymphoid Cells in Inflammation and Immunity
Andrew N. J. McKenzie et al.
IMMUNITY (2014)
Development, Differentiation, and Diversity of Innate Lymphoid Cells
Andreas Diefenbach et al.
IMMUNITY (2014)
T Follicular Helper Cell Differentiation, Function, and Roles in Disease
Shane Crotty
IMMUNITY (2014)
A committed precursor to innate lymphoid cells
Michael G. Constantinides et al.
NATURE (2014)
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J. Chan et al.
NATURE IMMUNOLOGY (2014)
Mesenchymal Stromal Cells Support the Viability and Differentiation of Follicular Lymphoma-Infiltrating Follicular Helper T-Cells
Michael T. Brady et al.
PLOS ONE (2014)
Are natural killer cells superior CAR drivers?
Hans Klingemann
ONCOIMMUNOLOGY (2014)
A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
Yu-Hsiang Chang et al.
CANCER RESEARCH (2013)
Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphomapossible link with monocytic myeloid-derived suppressor cells
Tamar Tadmor et al.
HEMATOLOGICAL ONCOLOGY (2013)
Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12-and IL-15-Responsive IFN-γ-Producing Cells
Anja Fuchs et al.
IMMUNITY (2013)
Control of inflammation by integration of environmental cues by regulatory T cells
Ashutosh Chaudhry et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
T cell regulation of natural killer cells
Yann Kerdiles et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment
Seema Rawal et al.
JOURNAL OF IMMUNOLOGY (2013)
Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inflamed lung
Jennifer K. Bando et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
Fernando Calvo et al.
NATURE CELL BIOLOGY (2013)
TH2, allergy and group 2 innate lymphoid cells
Paula Licona-Limon et al.
NATURE IMMUNOLOGY (2013)
Human type 1 innate lymphoid cells accumulate in inflamed mucosa! tissues
Jochem H. Bernink et al.
NATURE IMMUNOLOGY (2013)
Regulatory T Cells: Mechanisms of Differentiation and Function
Steven Z. Josefowicz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes
Fabien Guilloton et al.
BLOOD (2012)
Transcriptional control of innate lymphoid cells
Jenny Mjosberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Identification of Innate IL-5-Producing Cells and Their Role in Lung Eosinophil Regulation and Antitumor Immunity
Masashi Ikutani et al.
JOURNAL OF IMMUNOLOGY (2012)
IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
Jiankun Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
Mark P. Chao et al.
BLOOD (2011)
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
Madhavi Challa-Malladi et al.
CANCER CELL (2011)
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
Marie Tosolini et al.
CANCER RESEARCH (2011)
CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease
Marius Strioga et al.
IMMUNOLOGY (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Christian Steidl et al.
NATURE (2011)
Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment
Andrew J. Clear et al.
BLOOD (2010)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1-Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
Bjorn Engelbrekt Wahlin et al.
CLINICAL CANCER RESEARCH (2010)
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH-B cell axis
C. Pangault et al.
LEUKEMIA (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy
Alan G. Ramsay et al.
BLOOD (2009)
Phase I Study of Ipilimumab, an Anti-CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
Stephen M. Ansell et al.
CLINICAL CANCER RESEARCH (2009)
High Numbers of Tumor-Infiltrating Programmed Cell Death 1-Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma
Joaquim Carreras et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
Sarah M. McWhirter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma
Katherine R. Calvo et al.
BLOOD (2008)
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Alexandar Tzankov et al.
HAEMATOLOGICA (2008)
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
Brian T. Fife et al.
IMMUNOLOGICAL REVIEWS (2008)
CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-κB activation and up-regulation of c-FLIP and BCl-xL
Marion Travert et al.
JOURNAL OF IMMUNOLOGY (2008)
Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis
Na-Ri Lee et al.
LEUKEMIA & LYMPHOMA (2008)
LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems
Joseph F. Grosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone
Minna Taskinen et al.
CLINICAL CANCER RESEARCH (2007)
CD8+T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma
Bjoern Engelbrekt Wahlin et al.
CLINICAL CANCER RESEARCH (2007)
The terminology issue for myeloid-derived suppressor cells
Dmitry I. Gabrilovich et al.
CANCER RESEARCH (2007)
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression
Francois Ghiringhelli et al.
IMMUNOLOGICAL REVIEWS (2006)
Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients
Tomas Alvaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Joaquim Carreras et al.
BLOOD (2006)
Attenuation of CD8+ T-cell function by CD4+CD25+ regulatory T cells in B-cell non-Hodgkin's lymphoma
Zhi-Zhang Yang et al.
CANCER RESEARCH (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and γδ T cells
SEA Street et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Memory CD8+ T cell differentiation:: initial antigen encounter triggers a developmental program in naive cells
SM Kaech et al.
NATURE IMMUNOLOGY (2001)
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
MJ Smyth et al.
INTERNATIONAL IMMUNOLOGY (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
